GlaxoSmithKline, the UK-based pharmaceuticals group previously accused of concealing sensitive information on its medicines, has pledged to make public the findings and details of all clinical trials within 18 months of their completion.In its latest corporate social responsibility report, the company says it will post on its clinical study register all research on new drugs.
Entradas
1 comentario:
Es decir, que hasta ahora no lo había. Qué miedo dan.
Publicar un comentario